1. In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial. (4th May 2018) Authors: Adotevi, O.; Godet, Y.; Galaine, J.; Lakkis, Z.; Idirene, I.; Certoux, J. M.; Jary, M.; Loyon, R.; Laheurte, C.; Kim, S.; Dormoy, A.; Pouthier, F.; Barisien, C.; Fein, F.; Tiberghien, P.; Pivot, X.; Valmary-Degano, S.; Ferrand, C.; Morel, P.; Delabrousse, E. Journal: Oncoimmunology Issue: Volume 7:Number 5(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗